| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +0.00% | +0.53% | -1.33% | +1.86% | +1.86% | — |
| 14d | 3 | +0.00% | +1.61% | -0.68% | +2.29% | +2.29% | — |
| 30d | 3 | +0.00% | +2.27% | +1.71% | +0.56% | +0.56% | — |
| 60d | 3 | +100.00% | -28.30% | -30.54% | +2.24% | +2.24% | — |
| 90d | 3 | +100.00% | -16.07% | -14.51% | -1.56% | -1.56% | — |
| 180d | 3 | +0.00% | +7.71% | -1.09% | +8.80% | +8.80% | — |
| 1y | 3 | +0.00% | +27.07% | +18.04% | +9.03% | +9.03% | — |
| 2y | 3 | +0.00% | +68.33% | +39.20% | +29.12% | +29.12% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| ACN ACCENTURE PLC | SALE Group Chief Exec - Health & PS | 5 | $212.44 | $1.1K | 22,469 | Feb 14, 2020 | Feb 19, 2020 ↗ |
| ACN ACCENTURE PLC | PURCHASEGRANT Stock grant | 23 | — | — | 22,474 | Feb 14, 2020 | Feb 19, 2020 ↗ |
| ACN ACCENTURE PLC | SALE Group Chief Exec - Health & PS | 959 | $206.81 | $198.3K | 22,451 | Feb 1, 2020 | Feb 4, 2020 ↗ |
| ACN ACCENTURE PLC | SALE Group Chief Exec - Health & PS | 1,783 | $209.71 | $373.9K | 23,410 | Jan 21, 2020 | Jan 23, 2020 ↗ |
| ACN ACCENTURE PLC | SALE Group Chief Exec - Health & PS | 301 | $208.03 | $62.6K | 31,509 | Jan 21, 2020 | Jan 23, 2020 ↗ |
| ACN ACCENTURE PLC | SALE Group Chief Exec - Health & PS | 6,316 | $209.10 | $1.32M | 25,193 | Jan 21, 2020 | Jan 23, 2020 ↗ |
| ACN ACCENTURE PLC | SALE Group Chief Exec - Health & PS | 669 | $208.81 | $139.7K | 31,810 | Jan 5, 2020 | Jan 7, 2020 ↗ |
| ACN ACCENTURE PLC | SALE Group Chief Exec - Health & PS | 577 | $210.25 | $121.3K | 32,479 | Jan 1, 2020 | Jan 3, 2020 ↗ |
| ACN ACCENTURE PLC | PURCHASEGRANT Stock grant | 3,567 | — | — | 33,056 | Jan 1, 2020 | Jan 3, 2020 ↗ |